February 23rd 2023
February 23rd 2023
NCCN Releases New Guidelines for Most Common Gynecologic Cancer
September 14th 2018The National Comprehensive Cancer Network (NCCN) released this week new treatment guidelines for patients for 2 uterine cancers, endometrial cancer, the most common gynecologic cancer, and a rare cancer called uterine sarcoma.
Read More
UIC Releases First Guidelines to Diagnose and Treat Perimenopausal Depression
September 8th 2018A team of multi-institutional clinicians and scientists have recently published the first-ever guidelines for the evaluation and treatment of perimenopausal depression, endorsed by the International Menopause Society, in Menopause and the Journal of Women’s Health.
Read More
HER2-Positive Breast Cancer Study Finds New Option to Avoid Cardiac Toxicity
September 7th 2018A new study found no differences in long-term outcomes associated with 2 different approaches to administering trastuzumab (Herceptin) with neoadjuvant chemotherapy in patients with HER2-positive breast cancer. Receiving the combination sequentially rather than concurrently eliminates the known cardiac toxicities associated when chemotherapy and HER2 therapy are given at the same time, researchers said.
Read More
Women More Likely to Survive Heart Attacks When Treated by Female Physicians
August 31st 2018A recent review of nearly 582,000 heart attack cases over the span of 19 years found that female patients had a significantly higher survival rate when treated by a female physician in the emergency department.
Read More
USPSTF Updates Cervical Cancer Screening Recommendations
August 21st 2018What type of cervical cancer screening should a woman get, if any, and how often? The latest recommendation from the United States Preventive Services Task Force (USPSTF) said Tuesday that it depends on a woman’s age and other factors.
Read More
PARP Inhibitor Increases PFS Over Chemotherapy in Advanced Breast Cancers, Study Finds
August 16th 2018A recent study found that the poly (ADP-ribose) polymerase (PARP) inhibitor talazoparib extended progression-free survival (PFS) and improved quality of life over chemotherapies for patients with metastatic human epidermal growth factor 2-negative breast cancer and mutations in the BRCA 1/2 genes.
Read More
Teaching via Web Conference Increases Adherence to Breast Radiation Guidelines
August 15th 2018A web-based teaching conference was found to be an effective teaching model to improve adherence to clinical pathway guidelines in a large radiation oncology network looking to improve compliance with dosimetric parameters in whole breast irradiation, according to a report published earlier this year.
Read More
National Lung Cancer Screening Guidelines Insufficient for Minorities, Study Finds
August 11th 2018Researchers recently evaluated data collected from a lung cancer screening program at the University of Illinois at Chicago (UIC) and compared results to the national lung cancer screening guidelines.
Read More
Small Benefit Seen in Adding Radiation to DCIS Plan for Breast Cancer
August 10th 2018Patients with ductal carcinoma in situ (DCIS) are often treated with radiation after lumpectomy, although it has remained unclear whether this can reduce the risk of dying from this noninvasive form of breast cancer. A new study published Friday said that the combination of the 2 treatments was associated with a small benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone.
Read More
Refusing Conventional Cancer Treatment for CAM Carries More Risk, Study Says
August 4th 2018Complementary medicine and alternative medicine (CAM) is estimated to be a multibillion business in the United States, but people who use it instead of conventional cancer treatment have a 2-fold risk of death, a recent study in JAMA Oncology reported. Patients using or considering CAM are unlikely to discuss it with their doctors, who should proactively inform patients of the risk, the study said.
Read More
Collaborative Care Intervention Did Not Improve Health Status of Patients With Heart Failure
July 27th 2018In a recent study, researchers looked to determine whether a symptom and psychosocial collaborative care intervention would improve heart failure–specific health status, depression, and symptom burden in patients with heart failure.
Read More
Geography Influences Type of Posttreatment Imaging Received After Early Breast Cancer
July 24th 2018A study of over 35,000 women with early-stage breast cancer found that where you live makes a difference in terms of what kind of posttreatment imaging is received, due to geographic variation.
Read More
FDA Expands Use of Ribociclib in Breast Cancer
July 20th 2018The FDA has expanded its approval of ribociclib (Kisqali) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer under 2 new pilot programs to make the development and review of cancer drugs more efficient.
Read More
Do Breakthrough Therapies Need More Rigorous Evaluation?
July 18th 2018A new study published in JAMA reviewed the premarket development and review times of drugs approved between 2012 and 2017 that were granted Breakthrough Therapy designation and found that the crucial studies that supported these approvals lacked key features, including randomization, double-blinding, and control groups.
Read More